Bribery, kickbacks, and fake research: Study exposes the dark side of Pharma

Filed by Elara Myst

 By Paul Anthony TaylorGlobal Research, August 21, 2026 A remarkable study published earlier this year shed further light on a side of the pharma industry that continues to receive remarkably little attention from the mainstream/legacy media: the deliberate use of bribery and other corrupt practices to increase drug sales, influence prescribing, and secure favorable treatment from governments and regulators. Published online by Cambridge University Press in February 2026, the study ...